Jian-yun Dong

发表

The present and future for gene and viral therapy of directly accessible prostate and squamous cell cancers of the head and neck.

A. El-Zawahry, J. Norris, M. Tavassoli, 2005, Future oncology.

Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy.

A. Bielawska, Y. Hannun, Joseph Cheng, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

An increased transforming growth factor beta receptor type I:type II ratio contributes to elevated collagen protein synthesis that is resistant to inhibition via a kinase-deficient transforming growth factor beta receptor type II in scleroderma.

S. Jabłońska, J. Pannu, M. Trojanowska, 2004, Arthritis and rheumatism.

CD74: a potential novel target for triple-negative breast cancer

Jian-yun Dong, B. Tian, Yuhong Zhang, 2012, Tumor Biology.

In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer

S. Sudarshan, J. Norris, M. Hyer, 2005, Cancer Gene Therapy.

Involvement of sphingolipids in apoptin-induced cell killing.

A. Bielawska, Y. Hannun, J. Bielawski, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Defective function of the cystic fibrosis-causing missense mutation G551D is recovered by genistein.

R. Moss, Lei Zhang, Jian-yun Dong, 1999, American journal of physiology. Cell physiology.

rapid communication Defective function of the cystic ﬁbrosis-causing missense mutation G551D is recovered by genistein

R. Moss, Lei Zhang, Jian-yun Dong, 1999 .

Tim-3-expressing macrophages are functionally suppressed and expanded in oral squamous cell carcinoma due to virus-induced Gal-9 expression

Jian-yun Dong, Dawei Wang, Lijun Cheng, 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression

Y. Hannun, S. Sudarshan, J. Norris, 2003, Cancer Gene Therapy.

Ceramide, Ceramidase, and FasL Gene Therapy in Prostate Cancer

A. Bielawska, Y. Hannun, C. Landen, 2005 .

Acid ceramidase inhibition: a novel target for cancer therapy.

A. Bielawska, Y. Hannun, J. Bielawski, 2008, Frontiers in bioscience : a journal and virtual library.

Bystander effect contributes to the antitumor efficacy of CaSm antisense gene therapy in a preclinical model of advanced pancreatic cancer.

W. Gillanders, D. Watson, D. Cole, 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

Downregulation of c-FLIP Sensitizes DU145 Prostate Cancer Cells to Fas-Mediated Apoptosis

J. Reed, S. Sudarshan, Youngsoo Kim, 2002, Cancer biology & therapy.

Improving the transcriptional regulation of genes delivered by adenovirus vectors.

Jian-yun Dong, J. Woraratanadharm, S. Rubinchik, 2003, Methods in molecular medicine.

Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector

Hong-gang Yu, J. Norris, Jian-yun Dong, 2003, Cancer Gene Therapy.

Establishing a murine pancreatic cancer CaSm model: up-regulation of CaSm is required for the transformed phenotype of murine pancreatic adenocarcinoma.

W. Gillanders, P. Watson, D. Watson, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

HPV-induced tongue cancer patients develop different types of HPV-specific CD 4 + T cell responses , which is associated with disease prognosis

Jian-yun Dong, Dawei Wang, Lijun Cheng, 2016 .

Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase.

J. Dong, T. Townes, Jian-yun Dong, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis.

J. Norris, M. Hyer, Jian-yun Dong, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Combined therapeutic use of AdGFPFasL and small molecule inhibitors of ceramide metabolism in prostate and head and neck cancers: a status report

A. Bielawska, Y. Hannun, L. Obeid, 2006, Cancer Gene Therapy.

A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression.

F. Fan, J. Dong, H. Yu, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.